UAE Flu Diagnostic And Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The UAE flu diagnostic and treatment market is projected to grow at a CAGR of 8.76% throughout the forecast period to reach a market size of US$185.051 million by 2027. The market was valued at US$102.775 million in 2020.

Seasonal flu outbreaks and the high purchasing power of the population

 The market in the United Arab Emirates is poised to grow at a slow CAGR throughout the forecast period as the market growth in the country is primarily based on the seasonal outbreak of flu throughout the country only. Furthermore, the high purchasing power of the people coupled with the presence of a world-class healthcare system in the country is also some of the factors which are expected to collectively contribute to the market growth in the UAE during the next five years.

Development of the private and public healthcare sectors to boost the growth

The country’s healthcare is regulated at the federal and emirate levels. Furthermore, the continuously developing private healthcare sector of the country is also projected to propel the growth opportunities for the market to surge throughout the forecast period and beyond.

In addition, the availability of a well-established public healthcare system that is majorly government-funded with the aim of delivering high-quality health services and treatments to the population of the country is also anticipated to positively impact the United Arab Emirates flu diagnostic and treatment market growth during the coming years. Furthermore, the high incidence of seasonal flu in the country is also leading to significant market growth throughout the forecast period and beyond.

The UAE’s flu diagnostic and treatment market has been segmented on the basis of the type of flu, offering, age group, and end-user. Based on the type of flu, the market has been classified into type A and type B. By type of flu, type A is projected to hold a notable market share due to the high number of diagnosed cases with type A influenza virus. However, type B flu is anticipated to surge at a significant rate due to the rising prevalence of flu cases with type B flu.

The market has been divided into three age groups: 0-14 years, 15-64 years, and >=65 years. By offering, the market has been segmented into diagnostics and therapeutics. Based on the age group, the 15-64 age group segment is projected to show decent growth over the next five years.

By the end-user, the segmentation has been done based on the hospital laboratory, outpatient clinic, and reference laboratory. The hospital laboratory segment is anticipated to hold a noteworthy market share on account of the presence of well-established facilities throughout the country, coupled with the high purchasing power of the people, which is also supporting the growth of this segment.

Key Developments:

• October 2021: Abu Dhabi Health Services Company (Seha), launched an annual flu vaccine campaign to protect residents across the emirate. The vaccine was available free of cost for people aged above 50 years and children aged 19 years or below.
• October 2020: The Dubai Health Authority (DHA) has announced the launch of its Seasonal Influenza Campaign which aims to raise awareness about the importance of vaccination. The vaccination was offered across all the primary health care centres and medical fitness centres.

COVID-19 Impact:

The outbreak of the pandemic has impacted the market growth across UAE. During the pandemic outbreak, healthcare companies and manufacturers started producing surface and skin disinfectants to curb the spread of the virus across the nation. People across the country have started using medical gloves, masks, and sanitizers which has stopped the transmission of the virus and dropped the flu cases to a certain extent. However, the government of UAE has launched various campaigns to provide medical jabs to people in order to protect them from the flu which has significantly contributed to the overall market growth. The market is anticipated to grow in the future owing to the rise in the demand for rapid diagnostic tests and decreasing COVID-19 cases.

Segmentation

• By Type of Flu
  • Type A
  • Type B
• By Offering
  • Diagnostics
    • Rapid Influenza Diagnostic Test
    • Rapid Molecular Assay
    • Others
  • Therapeutics
• By Age Group
  • 0-14 Years
  • 15-64 Years
  • >=65 Years
• By End-User
  • Hospital Laboratory
  • Outpatient Clinic
  • Reference Laboratory

---